Alkermes (ALKS) stock Forecast for 2021 – 2025

Alkermes (ALKS) stock Forecast for 2022 – 2026

Last update: December 3, 2022 (12:33)

Sector: Healthcare

The share price of Alkermes plc (ALKS) now

What analysts predict: $32.22

52-week high/low: $32.79 / $21.24

50/200 Day Moving Average: $22.96 / $26.1

This figure corresponds to the average price over the previous 50/200 days. For Alkermes stocks, the 50-day moving average is the support level today.

For Alkermes stocks, the 200-day moving average is the resistance level today.

Are you interested in Alkermes plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alkermes stock price in 2022, 2023, 2024, 2025, 2026. How much will one Alkermes share be worth in 2022 - 2026?

When should I take profit in Alkermes stock? When should I record a loss on Alkermes stock? What are analysts' forecasts for Alkermes stock? What is the future of Alkermes stock? We forecast Alkermes stock performance using neural networks based on historical data on Alkermes stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Alkermes stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alkermes shares. This happens once a day.




Historical and forecast chart of Alkermes stock

The chart below shows the historical price of Alkermes stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alkermes stock price can be found in the table below.

Long-term forecasts by years.

Alkermes daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 05 26.88 26.69 27.52 3.09
Dec 06 26.70 26.37 27.25 3.34
Dec 07 26.95 26.69 27.34 2.46
Dec 08 26.13 25.78 26.33 2.14
Dec 09 26.19 25.93 26.53 2.33
Dec 10 26.03 25.43 26.69 4.98
Dec 11 26.39 26.10 26.57 1.81
Dec 12 26.02 25.50 26.39 3.49
Dec 13 26.70 26.38 27.20 3.11
Dec 14 25.99 25.72 26.24 2.01
Dec 15 25.73 25.53 26.18 2.55
Dec 16 26.54 26.16 26.89 2.79
Dec 17 26.16 25.87 26.79 3.56
Dec 18 26.02 25.69 26.68 3.82
Dec 19 25.68 25.26 25.85 2.34
Dec 20 25.80 25.22 26.38 4.58
Dec 21 26.14 25.65 26.46 3.16
Dec 22 26.31 26.04 26.74 2.68
Dec 23 26.65 26.35 27.04 2.59
Dec 24 26.07 25.86 26.56 2.71
Dec 25 26.45 25.91 26.99 4.15
Dec 26 25.93 25.72 26.46 2.87
Dec 27 26.04 25.80 26.41 2.39
Dec 28 26.29 25.91 26.81 3.47
Dec 29 26.56 25.88 26.78 3.48
Dec 30 27.15 26.77 27.81 3.89
Dec 31 27.28 27.00 27.73 2.68
Jan 01 27.08 26.68 27.55 3.25
Jan 02 26.83 26.46 27.50 3.93
Jan 03 26.29 25.78 26.46 2.64

Alkermes Daily Price Targets


Alkermes Stock Forecast 12-05-2022.

Forecast target price for 12-05-2022: $26.88.
Positive dynamics for Alkermes shares will prevail with possible volatility of 3.001%.
Pessimistic target level: 26.69
Optimistic target level: 27.52

Alkermes Stock Forecast 12-06-2022.

Forecast target price for 12-06-2022: $26.70.
Negative dynamics for Alkermes shares will prevail with possible volatility of 3.230%.
Pessimistic target level: 26.37
Optimistic target level: 27.25

Alkermes Stock Forecast 12-07-2022.

Forecast target price for 12-07-2022: $26.95.
Positive dynamics for Alkermes shares will prevail with possible volatility of 2.397%.
Pessimistic target level: 26.69
Optimistic target level: 27.34

Alkermes Stock Forecast 12-08-2022.

Forecast target price for 12-08-2022: $26.13.
Negative dynamics for Alkermes shares will prevail with possible volatility of 2.096%.
Pessimistic target level: 25.78
Optimistic target level: 26.33

Alkermes Stock Forecast 12-09-2022.

Forecast target price for 12-09-2022: $26.19.
Positive dynamics for Alkermes shares will prevail with possible volatility of 2.275%.
Pessimistic target level: 25.93
Optimistic target level: 26.53

Alkermes Stock Forecast 12-10-2022.

Forecast target price for 12-10-2022: $26.03.
Negative dynamics for Alkermes shares will prevail with possible volatility of 4.744%.
Pessimistic target level: 25.43
Optimistic target level: 26.69

ALKS (ALKS) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Dec. 25.11 22.72 28.09 19.14

Alkermes forecast for this year


Alkermes Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $25.1051. Pessimistic: $22.72. Optimistic: $28.09



Alkermes (ALKS) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 25.75 24.83 28.02 11.40
Feb 24.56 23.56 27.82 15.31
Mar 23.56 21.92 26.33 16.74
Apr 24.88 23.70 28.06 15.53
May 26.58 24.41 29.74 17.93
Jun 24.86 21.52 26.25 18.03
Jul 24.48 22.65 27.18 16.69
Aug 22.94 21.22 24.46 13.23
Sep 23.37 21.50 25.91 17.02
Oct 19.67 18.40 20.41 9.83
Nov 17.97 16.20 18.58 12.82
Dec 17.39 16.18 18.57 12.89

Alkermes (ALKS) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 17.24 15.69 17.85 12.15
Feb 17.06 16.22 18.72 13.33
Mar 19.06 17.83 20.04 11.00
Apr 18.97 16.90 20.29 16.69
May 21.19 19.03 23.17 17.88
Jun 20.62 19.39 22.26 12.91
Jul 22.09 20.62 23.85 13.54
Aug 21.98 19.73 24.55 19.63
Sep 21.30 18.95 22.43 15.50
Oct 17.79 15.76 19.51 19.22
Nov 17.03 15.50 17.79 12.86
Dec 19.87 17.37 21.76 20.18

Alkermes (ALKS) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 23.01 20.82 25.09 17.00
Feb 23.87 21.72 24.69 12.00
Mar 25.25 22.64 28.22 19.78
Apr 24.52 21.48 26.48 18.89
May 24.27 21.43 25.18 14.91
Jun 26.01 24.77 28.00 11.53
Jul 28.93 27.94 30.84 9.41
Aug 27.94 25.00 29.03 13.91
Sep 26.66 25.12 29.65 15.28
Oct 28.43 25.24 31.18 19.06
Nov 28.14 26.03 31.72 17.94
Dec 25.94 23.82 29.46 19.16

Alkermes (ALKS) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 25.63 23.54 28.07 16.14
Feb 27.20 25.81 28.54 9.56
Mar 29.28 25.74 31.72 18.83
Apr 24.60 21.55 27.40 21.37
May 23.34 21.48 25.53 15.86
Jun 24.18 23.23 27.22 14.65
Jul 23.52 20.72 24.56 15.63
Aug 26.64 24.60 28.04 12.27
Sep 28.18 27.22 29.23 6.88
Oct 26.45 24.43 29.24 16.46
Nov 28.48 26.44 29.64 10.78
Dec 29.54 26.03 32.66 20.30

Alkermes information and performance

Alkermes plc is an Irish biopharmaceutical company that researches, develops and markets pharmaceutical products used in a variety of therapeutic areas around the world. The company’s products include drugs for the treatment of schizophrenia, schizoaffective, depressive and bipolar disorder, alcohol and opioid addiction, aids to improve walking in adults with multiple sclerosis, and a drug for the treatment of type 2 diabetes. The company serves pharmaceutical wholesalers, specialized pharmacies and distributors.

Alkermes Address

CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, IE

Market Capitalization: 3 976 350 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -39 973 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -1057.29

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.381

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.142
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 588.24

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.36

Enterprise Value (EV) /Revenue

EV To EBITDA: -68.64

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 164312000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.